Christopher Brooke
Chief Operating Officer at SwanBio Therapeutics, Inc.
Net worth: 183 825 $ as of 31/05/2024
Christopher Brooke active positions
| Companies | Position | Start | End |
|---|---|---|---|
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Chief Operating Officer | 16/10/2023 | - |
Career history of Christopher Brooke
Former positions of Christopher Brooke
| Companies | Position | Start | End |
|---|---|---|---|
| AYTU BIOPHARMA, INC. | Chief Operating Officer | 14/11/2022 | 13/10/2023 |
| Corporate Officer/Principal | 01/04/2021 | 14/11/2022 | |
| Rumpus Therapeutics | Founder | - | - |
Training of Christopher Brooke
| Colgate University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistics
International
| United States | 6 |
Operational
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| AYTU BIOPHARMA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Rumpus Therapeutics | |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Health Technology |
- Stock Market
- Insiders
- Christopher Brooke
- Experience
